Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

SHINE Technologies Awarded $32M by DOE/NNSA to Support Production of Molybdenum-99

Jul 17, 2024•almost 2 years ago

Contract Type

contract

JanesvilleManufacturingEnergyRenewable Energy

Description

SHINE Technologies has been awarded $32 million from the Department of Energy's National Nuclear Security Administration (DOE/NNSA) to support the construction of Chrysalis, its large-scale medical isotope facility in Janesville, Wisconsin. This funding aims to establish a reliable, U.S.-produced supply of molybdenum‑99 (Mo-99) and address chronic shortages of critical medicine.

Company Information

Company

SHINE

Location

Janesville, Wisconsin, United States

About

SHINE is a next-generation fusion technology company headquartered in Janesville, Wisconsin, developing safe, cost-efficient, and environmentally responsible fusion-based solutions across neutron testing, medical isotope production, and nuclear waste recycling. With commercialized and scaling technologies supporting critical healthcare diagnostics and cancer therapies, and a long-term mission to commercialize fusion energy, SHINE follows a commercially driven deep-tech model to advance technology, healthcare, and sustainable energy worldwide.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for SHINE's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months